Literature DB >> 10548136

Medical illness in patients with schizophrenia.

L S Goldman1.   

Abstract

Research into the relationship between physical illness and schizophrenia has revealed that patients with schizophrenia may be at decreased risk for certain disorders, such as rheumatoid arthritis and allergies, but at increased risk for others, including substance abuse and polydipsia. Although such knowledge may ultimately help determine the underlying causes of schizophrenia, the principal concern of practicing clinicians should be to diagnose and treat medical comorbidity in individual patients. Nearly 50% of patients with schizophrenia have a comorbid medical condition, but many of these illnesses are misdiagnosed or undiagnosed. A fragmented health care system, lack of access to care, patient inability to clearly appreciate or describe a medical problem, and patient reluctance to discuss such problems all contribute to the lack of attention to medical problems in patients with schizophrenia. Psychiatrists and primary care practitioners who treat patients with schizophrenia should make an effort to uncover medical illnesses by using a structured interview or routine physical examination whenever a patient is seen for care.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548136

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  47 in total

1.  Physical health of people with severe mental illness.

Authors:  M Phelan; L Stradins; S Morrison
Journal:  BMJ       Date:  2001-02-24

2.  Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia.

Authors:  Lexie R Grove; William J Olesiuk; Alan R Ellis; Jesse C Lichstein; C Annette DuBard; Joel F Farley; Carlos T Jackson; Christopher A Beadles; Joseph P Morrissey; Marisa Elena Domino
Journal:  Gen Hosp Psychiatry       Date:  2017-03-07       Impact factor: 3.238

3.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

4.  Poor clinical outcomes among pneumonia patients with schizophrenia.

Authors:  Yi-Hua Chen; Hsiu-Chen Lin; Herng-Ching Lin
Journal:  Schizophr Bull       Date:  2010-03-25       Impact factor: 9.306

5.  Utilization and Adherence in Medical Homes: An Assessment of Rural-Urban Differences for People With Severe Mental Illness.

Authors:  Mona Kilany; Joseph P Morrissey; Marisa E Domino; Kathleen C Thomas; Pam Silberman
Journal:  Med Care       Date:  2018-10       Impact factor: 2.983

6.  Relationship between schizophrenia and diabetes mellitus: consideration based on physiogenomics data.

Authors:  Somsri Wiwanitkit; Viroj Wiwanitkit
Journal:  Indian J Psychol Med       Date:  2013-04

Review 7.  Postpsychotic depression in schizophrenia patients.

Authors:  Christian G Kohler; Elise A Lallart
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

8.  Physical illnesses among psychiatric outpatients in a tertiary care health institution: A prospective study.

Authors:  Gurvinder Pal Singh; B S Chavan; Paramleen Kaur; Shalini Bhatia
Journal:  Indian J Psychiatry       Date:  2006-01       Impact factor: 1.759

Review 9.  Role of the psychiatrist in the care of patients with hepatitis C and HIV/AIDS.

Authors:  Stephen Price; Juanita Goyette
Journal:  Psychiatr Q       Date:  2003

10.  European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods.

Authors:  Prisca Weiser; Thomas Becker; Carolin Losert; Köksal Alptekin; Loretta Berti; Lorenzo Burti; Alexandra Burton; Mojca Dernovsek; Eva Dragomirecka; Marion Freidl; Fabian Friedrich; Aneta Genova; Arunas Germanavicius; Ulaş Halis; John Henderson; Peter Hjorth; Taavi Lai; Jens Ivar Larsen; Katarzyna Lech; Ramona Lucas; Roxana Marginean; David McDaid; Maya Mladenova; Povl Munk-Jørgensen; Alexandru Paziuc; Petronela Paziuc; Stefan Priebe; Katarzyna Prot-Klinger; Johannes Wancata; Reinhold Kilian
Journal:  BMC Public Health       Date:  2009-08-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.